Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Thrombosis and Thrombolysis
Metadata
Title
Long-Term Anticoagulation Therapy for Atrial Fibrillation in Elderly Patients: Efficacy, Risk, and Current Patterns of Use
Authors
Danny McCormick
Jerry H. Gurwitz
Robert J. Goldberg
Jack Ansell
Publication date
01-04-1999
Publisher
Kluwer Academic Publishers
Published in
Journal of Thrombosis and Thrombolysis / Issue 2/1999
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1023/A:1008884004751

Other articles of this Issue 2/1999

Journal of Thrombosis and Thrombolysis 2/1999 Go to the issue

OriginalPaper

Hospital-Based Approach to the Management of Venous Thromboembolism

OriginalPaper

Anticoagulation Services: Quality Improvement Direction <197> Pursuing a Certification Process

OriginalPaper

Management of Narrow Therapeutic Index Drugs

OriginalPaper

Advances in the Medical Management of Acute Coronary Syndromes

OriginalPaper

In-Hospital Approach to Newly Recognized Atrial Fibrillation

OriginalPaper

Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits